Alzheimer's Disease

Evidence based Dementia Practice

Volumn , Issue , 2008, Pages 228-259

  Knopman, David ^a   Ritchie, Karen ^b   Polge, Catherine ^b   Alafuzoff, Irina ^c   Soininen, Hilkka ^c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b Montpellier 1 University   (France)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4244180613     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470752340.ch19     Document Type: Chapter

References (306)

1. Akesson, H.O. (1969) A population study of senile and arteriosclerotic psychoses. Human Heredity 19, 546-566.
2. Alafuzoff, I., Helisalmi, S., Mannermaa, A., Riekkinen, P.S.R. & Soininen, H. (1999) ß-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients. Stroke 30, 613-618.
3. Amaducci, L.A., Fratiglioni, L., Rocca, W.A., et al. (1986) Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology 36, 922-931.
4. American Psychiatric Association. (1980) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. American Psychiatric Association, Washington, DC.
5. American Psychiatric Association. (1987) Diagnostic and Statistical Manual of Mental Disorders, Revised 3rd edn. American Psychiatric Association, Washington, DC.
6. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC.
7. Andreasen, N., Vanmechelen, E., Van de Voorde, A. et al. (1998) Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. Journal of Neurological and Neurosurgical Psychiatry 64, 298-305.
8. Arnold, S.E., Franz, B.R., Trojanowski, J.Q., Moberg, P.J. & Gur, R.E. (1996) Glial fibrillary acidic proteinimmunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathologica 91, 269-277.
9. Ball, M.J. & Lo, P. (1977) Granulovacuolar degeneration in the aging brain and in dementia. Journal of Neuropathology and Experimental Neurology 36, 474-487.
10. Ball, M.J. & Murdoch, G.H. (1997) Neuropathological criteria for the diagnosis of Alzheimer's disease: are we really ready yet? Neurobiological Aging 18, S3-S12.
11. Ball, M.J. (1977) Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with aging and dementia. A quantitative study. Acta Neuropathologica 37, 11-118.
12. Barclay, L.L., Zemcov, A., Blass, J.P. & Sansone, J. (1985) Survival in Alzheimer's disease and vascular dementias. Neurology 35, 834-840.
13. Bartoo, G.T., Nochlin, D., Chang, D., Yongmin, K. & Sumi, M. (1997) The mean Aß load in the hippocampus correlates with duration and severity of dementia in subgroups of. Alzheimer's Disease. Journal of Neuropathology and Experimental Neurology 56, 531-540.
14. Beard, C.M., Kokmen, E., Sigler, C., Smith, G.E., Petterson, T. & O'Brien, P.C. (1996) Cause of death in Alzheimer's disease. Annals of Epidemiology 6, 195-200.
15. Becker, J.T., Huff, F.J., Nebes, R.D., Holland, A. & Boller, F. (1988) Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progression. Archives of Neurology 45, 263-268.
16. Berg, L., McKeel, D.W., Miller, P. et al. (1998) Clinicopathological studies in cognitively healthy aging and Alzheimer's disease. Archives of Neurology 55, 326-335.
17. Binetti, G., Cappa, S.F., Magni, E., Padovani, A., Bianchetti, A. & Trabucchi, M. (1998) Visual and spatial perception in the early phase of Alzheimer's disease. Neuropsychology 12, 29-33.
18. Blacker, D., Wilcox, M.A., Laird, N.M. et al. (1998) Alpha- 2-macroglobulin is genetically associated with Alzheimer's disease. Nature (Genetics) 19, 357-360.
19. Bone, M.R., Bebbington, A.C., Jagger, C., Morgan, K. & Nicolaas, G. (1995) Health Expectancy and its Uses. HMSO, London, p. 90.
20. Bowen, J.D., Malter, A.D., Sheppard, L. et al. (1996) Predictors of mortality in patients diagnosed with probable Alzheimer's disease. Neurology 47, 433-439.
21. Braak, H. & Braak, E. (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica (Berlin) 82, 239-259.
22. Braak, H. & Braak, E. (1997) Diagnostic criteria for neuropathological assessment of Alzheimer's disease. Neurobiological Aging 18, S85-S88.
23. Breitner, J.C.S. (1996) Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiological Aging 17, 789-794.
24. Brodaty, H., McGilchrist, C., Harris, L. & Peters, K.E. (1993) Time until institutionalization and death in patients with dementia. Role of caregiver training and risk factors. Archives of Neurology 50, 643-650.
25. Brun, A. (1993) Frontal lobe degeneration of non- Alzheimer type revisited. Dementia 4, 126-131.
26. Brun, A., Gustafson, L. & Englund, E. (1990) Subcortical pathology of Alzheimer's disease. In: Alzheimer's Disease (eds Wurtman, R.J. et al.). Advances in Neurology 51, 73-77.
27. Burkhardt, C.R., Filley, C.M., Kleinschmidt-DeMaster, B.K., de la Monte, S., Norenberg, M.D. & Schneck, S.A. (1988) Diffuse Lewy Body disease and progressive dementia. Neurology 38, 1520-1528.
28. Burns, A., Lewis, G., Jacoby, R. & Levy, R. (1991) Factors affecting survival in Alzheimer's disease. Psychological Medicine 21, 363-370.
29. Buschke, H., Sliwinski, M.J., Kuslansky, G. & Lipton, R.B. (1997) Diagnosis of early dementia by the Double Memory Test: encoding specificity improves diagnostic sensitivity and specificity. Neurology 48, 989-997.
30. Cahill, S. & Shapiro, M. (1993) I think he might have hit me once. Aggression towards care-givers in dementia care. Australian Journal of Ageing 12, 10-15.
31. Carpenter, A.F., Carpenter, P.W. & Markesbery, W.R. (1993) Morphometric analysis of microglia in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 52 (6), 601-608.
32. Checler, F. (1995) Processing of the ß-amyloid precursor protein and its regulation in Alzheimer's disease. Journal of Neurochemistry 65, 1431-1444.
33. Chui, H.C., Lyness, S.A., Sobel, E. & Schneider, L.S. (1994) Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Archives of Neurology 51, 676-681.
34. Citron, M., Oltersdorf, T., Haass, C. et al. (1992) Mutation of the ß-amyloid precursor protein in familial Alzheimer's disease increases ß-protein production. Nature 360, 672-674.
35. Clark, C.M., Ewbank, D., Lerner, A. et al. (1997) The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 49, 70-75.
36. Claus, J.J., van Harskamp, F., Breteler, M.M. et al. (1994) The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study. Neurology 44, 454-461.
37. Coleman, P.D. (1997) Research uses of neuropathological data. Neurobiological Aging 18, S98-S98.
38. Colerick, E.J. & George, L.K. (1986) Predictors of institutionalization among caregivers of patients with Alzheimer's disease. Journal of the American Geriatric Society 34, 493-498.
39. Consensus report. (1998) Consensus report of the Working Group on 'Molecular and Biochemical Markers of Alzheimer's Disease', The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging. Neurobiological Aging 19, 109-116.
40. Corder, E., Saunders, A.M. & Risch, N.J. (1994) Apolipoprotein E. Type 2 Allele decreases the risk of late onset Alzheimer disease. Nature (Genetics) 7, 180-183.
41. Corder, E.H., Saunders, A.M., Strittmatter, W.J. et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
42. Crook, R., Verkkoniemi, A., Perez-Tur, J. et al. (1998) A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nature (Medicine) 4, 452-455.
43. Cruts, M., van Duijn, C.M., Backhovens, H. et al. (1998) Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Human Molecular Genetics 1, 43-51.
44. Crystal, H.A., Horoupian, D.S., Katzman, R. & Jotkowitz, S. (1982) Biopsy-proved Alzheimer disease presenting as a right parietal lobe syndrome. Annals of Neurology 12, 186-188.
45. Cummings, B.J., Pike, C.J., Shankel, R. & Cotman, C.W. (1996) ß-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiological Aging 17, 921-933.
46. Dartigues, J.F., Gagnon, M., Michel, P. et al. (1991) Le programme de recherche PAQUID sur l'épidémiologie de la démence. Review of Neurology 147, 225-230.
47. de la Monte, S.M., Ghanbari, K., Frey, W.H. et al. (1997) Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid. Journal of Clinical Investigations 100, 3093-3104.
48. Delacourte, A. (1990) General and dramatic glial reaction in Alzheimer brains. Neurology 40, 33-37.
49. Devanand, D.P., Jacobs, D.M., Tang, M.X. et al. (1997) The course of psychopathologic features in mild to moderate Alzheimer disease. Archives of General Psychiatry 54, 257-263.
50. Dickson, D.W. (1997a) The pathogenesis of senile plaques. Journal of Neuropathology and Experimental Neurology 56, 321-339.
51. Dickson, D.W. (1997b) Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies. Neurobiological Aging 18, S21-S26.
52. Dickson, D.W., Farlo, J., Davies, P., Crystal, H., Fuld, P. & Yen, S.-H.C. (1988) Alzheimer's disease. A doublelabeling immunohistochemical study of senile plaques. American Journal of Pathology 132, 86-101.
53. DiPatre, P.L. & Gelman, B.B. (1997) Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus. Journal of Neuropathology and Experimental Neurology 2, 143-149.
54. Duyckaerts, C. & Hauw, J.J. (1997) Diagnosis and staging of Alzheimer's disease. Neurobiological Aging 18, S33-S42.
55. Egensperger, R., Kösel, S. von Ulrich, E. & Graeber, M.B. (1998) Microglia activation in Alzheimer's disease: association with ApoE genotype. Brain Pathology 8, 439-447.
56. Ely, M., Melzer, D., Brayne, C. & Opit, L. (1995) The Cognitively Frail Elderly. Estimating characteristics and needs for service in populations of people with cognitive disability, including dementia. Report to the NHS Mental Health and R & D programme, NHS Executive.
57. Erkinjuntti, T., Ostbye, T., Steenhuis, R. & Hachinski, V. (1997) The effect of different diagnostic criteria on the prevalence of dementia. New England Journal of Medicine 337, 1667-1674.
58. Esiri, M.M. & Wilcock, G.K. (1984) The olfactory bulb in Alzheimer's disease. Journal of Neurological and Neurosurgical Psychiatry 47, 56-60.
59. Evans, D.A., Smith, L.A., Scherr, P.A., Albert, M.S., Funkenstein, H.H. & Hebert, L.E. (1991) Risk of death from Alzheimer's disease in a community population of older persons. American Journal of Epidemiology 134, 403-412.
60. Faber-Langendoen, K., Morris, J.C., Knesevich, J.W., LaBarge, E., Miller, J.P. & Berg, L. (1988) Aphasia in senile dementia of the Alzheimer type. Annals of Neurology 23, 365-370.
61. Farrer, L.A., Cupples, L.A., Haines, J.L. et al. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Journal of the American Medical Association 278, 1349-1356.
62. Ferm, L. (1974) Behavioural activities in demented geriatric patients. Study based on evaluations made by nursing staff members and on patients' scores on a simple psychometric test. Gerontological Clinician 16, 185-194.
63. Fox, N.C., Freeborough, P.A. & Rossor, M.N. (1996) Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet 348, 94-97.
64. Freels, S., Cohen, D., Eisdorfer, C. et al. (1992) Functional status and clinical findings in patients with Alzheimer's disease. Journal of Gerontology 47, M177-M182.
65. Funkenstein, H.H., Albert, M.S., Cook, N.R. et al. (1993) Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease. A communitybased study. Archives of Neurology 50, 51-56.
66. Galasko, D., Bennett, D., Sano, M. et al. (1997a) An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer's Disease and Associated Disorders 11 (Supplement 2), S33-S39.
67. Galasko, D., Chang, L., Motter, R. et al. (1998) High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Archives of Neurology 55, 937-945.
68. Galasko, D., Clark, C., Chang, L. et al. (1997b) Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology 48, 632-635.
69. Galasko, D., Corey-Bloom, J. & Thal, L.J. (1991) Monitoring progression in Alzheimer's disease. Journal of the American Geriatrics Society 39, 932-941.
70. Galasko, D., Edland, S.D., Morris, J.C., Clark, C., Mohs, R. & Koss, E. (1995) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years. Neurology 45, 1451-1455.
71. Galasko, D., Hansen, L.A., Katzman, R. et al. (1994) Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Archives of Neurology 51, 888-895.
72. Galasko, D., Klauber, M.R., Hofstetter, C.R., Salmon, D.P., Lasker, B. & Thal, L.J. (1990) The Mini Mental State Examination in the early diagnosis of Alzheimer's disease. Archives of Neurology 47, 49-52.
73. Galasko, D., Kwo on Yuen, P.F., Klauber, M.R. & Thal, L.J. (1990) Neurological findings in Alzheimer's disease and normal aging. Archives of Neurology 47, 625-627.
74. Gambetti, P. (1997) Current diagnostic criteria for assessment of neuropathological Alzheimer's disease. Neurobiological Aging 18, S95-S96.
75. Gearing, M., Mirra, S.S., Hedreen, J.C., Sumi, S.M., Hansen, L.A. & Heyman, A. (1995) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 45, 461-466.
76. Gearing, M., Schneider, J.A., Rebeck, G.W., Hyman, B.T. & Mirra, S.S. (1995) Alzheimer's disease with and without coexistent Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology 45, 1985-1990.
77. Geddes, J.W., Tekirian, T.L., Soultanian, N.S., Ashford, J.W., Davis, D.G. & Markesbery W.R. (1997) Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease. Neurobiological Aging 18, S99-S105.
78. Giaccone, G., Pedrotti, B., Migheli, A. et al. (1996) ßPP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. American Journal of Pathology 148, 79-87.
79. Giannakopoulos, P., Gold, G., Duc, M., Michel, J.P., Hof, P.R. & Bouras, C. (1999) Neuroanatomic correlates of visual agnosia in Alzheimer's disease: a clinicopathologic study. Neurology 52, 71-77.
80. Gibson, P. & Tomlinson, B.E. (1977) The numbers of Hirano bodies in the hippocampus of normal and demented subjects with Alzheimer's disease. Journal of Neurological Science 33, 199-206.
81. Gilley, D.W., Wilson, R.S., Beckett, L.A. & Evans, D.A. (1997) Psychotic symptoms and physically aggressive behavior in Alzheimer's disease. Journal of the American Geriatric Society 45, 1074-1079.
82. Goate, A., Chartier-Harlin, M.C., Mullan, M. et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706.
83. Goedert, M. & Hasegawa, M. (1999) The tauopathies, toward an experimental model. American Journal of Pathology 154, 1-6.
84. Goedert, M. (1993) Tau protein and the neurofibrillary pathology in Alzheimer's Disease. Trends in Neuroscience 16, 460-465.
85. Goedert, M., Crowther, R.A. & Spillantini, M.G. (1998) Tau mutations cause frontotemporal dementia. Neuron 21, 955-958.
86. Goedert, M., Spillantini, M.G., Cairns, N.J. & Crowther, R.A. (1992) Tau protein of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168.
87. Gomez-Isla, T., Price, J.L., McKeel, D.W., Morris, J.C., Growdon, J.H. & Hyman, B.T. (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. Journal of Neuroscience 16, 4491-4500.
88. Gorelick, P.B., Nyenhuis, D.L., Garron, D.C. & Cochran, E. (1996) Is vascular dementia really Alzheimer's disease or mixed dementia? Neuroepidemiology 15, 286-290.
89. Graff-Radford, N.R., Bolling, J.P., Earnest, F.T., Shuster, E.A., Caselli, R.J. & Brazis, P.W. (1993) Simultanagnosia as the initial sign of degenerative dementia. Mayo Clinic Proceedings 68, 955-964.
90. Graff-Radford, N.R., Lin, S.C., Brazis, P.W. et al. (1997) Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease. Mayo Clinic Proceedings 72, 495-504.
91. Green, C.R., Mohs, R.C., Schmeidler, J., Aryan, M. & Davis, K.L. (1993) Functional decline in Alzheimer's disease: a longitudinal study. Journal of the American Geriatric Society 41, 654-661.
92. Green, J., Morris, J.C., Sandson, J., McKeel, D.W. Jr & Miller, J.W. (1990) Progressive aphasia: a precursor of global dementia? Neurology 40, 423-429.
93. Greenwald, B.S., Kramer-Ginsberg, E., Marin, D.B. et al. (1989) Dementia with coexistent major depression. American Journal of Psychiatry 146, 1472-1478.
94. Grober, E. & Kawas, C. (1997) Learning and retention in preclinical and early Alzheimer's disease. Psychological Aging 12, 183-188.
95. Growdon, J.H., Graefe, K., Tennis, M., Hayden, D., Schoenfeld, D. & Wray, S.H. (1997) Pupil dilation to tropicamide is not specific for Alzheimer disease. Archives of Neurology 54, 841-844.
96. Grubber, J.M., Saunders, A.M., Crane-Gatherum, A.R. et al. (1999) Analysis of association between Alzheimer's disease and the K variant of Butyrylcholinesterase (BCHE-K). Neuroscience Letters 9, 115-119.
97. Grut, M., Jorm, A.F., Fratiglioni, L., Forsell, Y., Viitanen, M. & Winblad, B. (1993) Memory complaints of elderly people in a population survey: variation according to dementia stage and depression. Journal of the American Geriatrics Society 41, 1295-1300.
98. Gurland, B.J., Copeland, J. & Kuriansky (1983) The Mind and Mood of Aging. Croom-Helm, London.
99. Hanninen, T., Hallikainen, M., Koivisto, K. et al. (1995) A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. Journal of the American Geriatrics Society 43, 1007-1015.
100. Hansen, L.A. & Terry, R.D. (1997) Position paper on diagnostic criteria for Alzheimer's disease. Neurobiological Aging 18, S71-S73.
101. Hansen, L.A. (1997) The Lewy body variant of Alzheimer's disease. Journal of Neural Transmission (Suppl.) 51, 83-93.
102. Hardy, J. & Higgins, G.A. (1992) Alzhheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
103. Hardy, J., Duff, K., Hardy, K.G., Perez-Tur, J. & Hutton, M. (1998) Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. Nature (Neuroscience) 5, 355-358.
104. Harpin, M.L., Delaére, P., Javoy-Agid, F. et al. (1990) Glial fibrillary acidic protein and beta A4 protein deposits in temporal lobe of aging brain and senile dementia of the Alzheimer type: relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles. Journal of Neuroscientific Research 27, 587-594.
105. Harrison, R., Savla, N. & Kafetz, K. (1990) Dementia, depression and physical disability in a London borough: a survey of elderly people in and out of residential care and implications for future developments. Age Ageing 19, 97-103.
106. Helisalmi, S., Linnaranta, K., Lehtovirta, M. et al. (1996) Screening for amyloid beta precursor protein codon 665, 670/671 and 717 mutations in Finnish patients with Alzheimer's disease. Neuroscience Letters 16, 61-64.
107. Henderson, V.W., Mack, W. & Williams, B.W. (1989) Spatial disorientation in Alzheimer's disease. Archives of Neurology 46, 391-394.
108. Herlitz, A., Hill, R.D., Fratiglioni, L. & Backman, L. (1995) Episodic memory and visuospatial ability in detecting and staging dementia in a community-based sample of very old adults. Journal of Gerontology 50, M107-M113.
109. Heston, L.L. & Mastri, A.R. (1982) Age at onset of Pick's and Alzheimer's dementia: implications for diagnosis and research. Journal of Gerontology 37, 422-424.
110. Heyman, A., Fillenbaum, G.G., Gearing, M. et al. (1999) The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIX. Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease. Neurology 9, 1839-1844.
111. Heyman, A., Peterson, B., Fillenbaum, G. & Pieper, C. (1996) The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology 46, 656-660.
112. Heyman, A., Peterson, B., Fillenbaum, G. & Pieper, C. (1997) Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience, part XVII. Neurology 48, 1304-1309.
113. Hiltunen, M., Mannermaa, A., Helisalmi, S. et al. (1998) Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late onset Alzheimer's disease patients. Neuroscience Letters 250, 69-71.
114. Hof, P.R., Bouras, C., Constantinidis, J. & Morrison, J.H. (1990) Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome. Journal of Neuropathology and Experimental Neurology 49, 168-184.
115. Hofman, A., Ott, A., Breteler, M.M.B. et al. (1997) Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 349, 151-154.
116. Hofman, A., Rocca, W.A. & Brayne, C. (1991) The prevalence of dementia in Europe. a collaborative study of 1980-90 findings. International Journal of Epidemiology 20, 736-748.
117. Holcomb, L., Gordon, M.N., McGowan, E. et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Medicine 4, 97-100.
118. Holmes, C., Cairns, N., Lantos, P. & Mann, A. (1999) Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. British Journal of Psychiatry 174, 45-50.
119. Holscher, C. (1998) Possible causes of Alzheimer's disease: amyloid fragments, free radicals, and calcium homeostasis. Neurobiological Disease 3, 129-141.
120. Homer, A. & Gilleard, C. (1990) Abuse of elderly people by their carers. British Medical Journal 301, 1359-1362.
121. Huff, F.J., Growdon, J.H., Corkin, S. & Rosen, T.J. (1987) Age at onset and rate of progression of Alzheimer's disease. Journal of the American Geriatric Society 35, 27-30.
122. Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A. & Martin, R.L. (1982) A new clinical scale for the staging of dementia. British Journal of Psychiatry 140, 566-572.
123. Hulette, C., Mirra, S.S., Wilkinson, W., Heyman, A., Fillenbaum, G. & Clark, C. (1995) The consortium to establish a registry for Alzheimer's disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology 45, 1991-1995.
124. Hutton, M. & Hardy, J. (1997) The presenilins and Alzheimer's disease. Human Molecular Genetics 6, 1639-1646.
125. Hyman, B.T. & Trojanowski, J.Q. (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease from National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 56, 1095-1097.
126. Hyman, B.T. (1997) The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies. Neurobiological Aging 18, S27-S32.
127. Itagaki, S., McGeer, P.L., Akiyama, H., Zhu, S. & Selkoe, D. (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer's disease. Journal of Neuroimmunology 24, 173-182.
128. Jack, C.R. Jr, Petersen, R.C., O'Brien, P.C. & Tangalos, E.G. (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 42, 183-188.
129. Jarvik, L.F. & Matsuyama, S.S. (1983) Parental stroke: risk factor for multi-infarct dementia? Lancet ii, 1025.
130. Jellinger, K.A. & Bancher, C. (1997) Proposal for reevaluation of current autopsy criteria for the diagnosis of Alzheimer's disease. Neurobiological Aging 18, S55-S65.
131. Jellinger, K.A. (1997) Morphological substrates of dementia in parkinsonism. A critical update. Journal of Neural Transmission 51 (Suppl.), 57-82.
132. Jobst, K.A., Barnetson, L.P. & Shepstone, B.J. (1998) Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM- III-R criteria, SPECT, X-ray, CT, and Apo e4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging. International Psychogeriatrics 10, 271-302.
133. Jobst, K.A., Hindley, N.J., King, E. & Smith, A.D. (1994) The diagnosis of Alzheimer's disease: a question of image? Journal of Clinical Psychiatry 55 (Suppl. 22), 31.
134. Jorm, A.F., Korten, A.E. & Henderson, A.S. (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatrica Scandinavica 76, 465-479.
135. Kamboh, M.I., Sanghera, D.K., Ferrell, R.E. & DeKosky, S.T. (1995) ApoE e4-associated Alzheimer's disease risk is modified by a-antichytrypsin polymorphism. Nature (Genetics) 11, 207-209.
136. Kanai, M., Matsubara, E., Isoe, K. et al. (1998) Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Annals of Neurology 44, 17-26.
137. Kanne, S.M., Balota, D.A., Storandt, M., McKeel, D.W. Jr & Morris, J.C. (1998) Relating anatomy to function in Alzheimer's disease: neuropsychological profiles predict regional neuropathology 5 years later. Neurology 50, 979-985.
138. Kardon, R.H. (1998) Drop the Alzheimer's drop test. Neurology 50, 588-591.
139. Katzman, R., Brown, T., Thal, L.J. et al. (1988) Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Annals of Neurology 24, 384-389.
140. Katzman, R., Hill, L.R., Yu, E.S. et al. (1994) The malignancy of dementia. Predictors of mortality in clinically diagnosed dementia in a population survey of Shanghai, China. Archives of Neurology 51, 1220-1225.
141. Kay, D.W.K., Holding, T.A., Jones, B. & Littler, S. (1991) Dependency in old age: a comparison of mental and physical factors. International Journal of Geriatric Psychiatry 6, 833-844.
142. Kehoe, P., Wavrant-De Vrieze, F., Cook, R. et al. (1999) A full genome scan for late onset Alzheimer's disease. Human Molecular Genetics 8, 237-245.
143. Khachaturian, Z.S. (1985) Diagnosis of Alzheimer's disease. Archives of Neurology 42, 1097-1105.
144. Khatoon, S., Grundke-Iqbal, I. & Iqbal, K. (1992) Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein. Journal of Neurochemistry 59, 750-753.
145. Killiany, R.J., Moss, M.B., Albert, M.S., Sandor, T., Tieman, J. & Jolesz, F. (1993) Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Archives of Neurology 50, 949-954.
146. Klatka, L.A., Schiffer, R.B., Powers, J.M. & Kazee, A.M. (1997) Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study [see comments]. Archives of Neurology 53, 35-42.
147. Knopman, D. & Gracon, S. (1994) Observations on the short-term 'natural history' of probable Alzheimer's disease in a controlled clinical trial. Neurology 44, 260-265.
148. Knopman, D.S., Kitto, J., Deinard, S. & Heiring, J. (1988) Longitudinal study of death and institutionalization in patients with primary degenerative dementia. Journal of the American Geriatric Society 36, 108-112.
149. Knopman, D.S. & Ryberg, S. (1989) A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Archives of Neurology 46, 141-145.
150. Knopman, D., Schneider, L., Davis, K. et al. (1996) Longterm tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group. Neurology 47, 166-177.
151. Kopelman, M.D. (1991) Frontal dysfunction and memory deficits in the alcoholic Korsakoff syndrome and Alzheimer-type dementia. Brain 114, 117-137.
152. Koss, E., Patterson, M.B., Ownby, R., Stuckey, J.C. & Whitehouse, P.J. (1993) Memory evaluation in Alzheimer's disease. Caregivers' appraisals and objective testing. Archives of Neurology 50, 92-97.
153. Kovacs, D.M., Fausett, H.J., Page, K.J. et al. (1996) Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature (Medicine) 2, 224-229.
154. Kraemer, H.C., Tinklenberg, J. & Yesavage, J.A. (1994) 'How far' vs 'how fast' in Alzheimer's disease. The question revisited. Archives of Neurology 51, 275-279.
155. Kramer, S.I. & Reifler, B.V. (1992) Depression, dementia, and reversible dementia. Clinical Geriatric Medicine 8, 289-297.
156. Kukull, W.A., Brenner, D.E., Speck, C.E. et al. (1994) Causes of death associated with Alzheimer disease: variation by level of cognitive impairment before death. Journal of the American Geriatrics Society 42, 723-726.
157. Kuusisto, J., Koivisto, K., Kervinen, K. et al. (1994) Association of apolipoprotein E phenotypes with lateonset Alzheimer's disease: a population-based study. British Medical Journal 309, 636-638.
158. Lawlor, B.A., Ryan, T.M., Schmeidler, J., Mohs, R.C. & Davis, K.L. (1994) Clinical symptoms associated with age at onset in Alzheimer's disease. American Journal of Psychiatry 151, 1646-1649.
159. Le Prince, G., Delaere, P., Fages, C., Duyckaerts, C., Hauw, J.-J. & Tardy, M. (1993) Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type. Neuroscience Letters 51, 71-73.
160. Lehmann, D.J., Johnston, C. & Smith, A.D. (1997) Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Human Molecular Genetics 11, 1933-1936.
161. Leibovici, D., Ritchie, K., Ledésert, B. & Touchon, J. (1996) Does education level determine the course of cognitive decline? Age & Ageing 55, 392-397.
162. Levine, D.N., Lee, J.M. & Fisher, C.M. (1993) The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology 43, 305-313.
163. Levy, M.L., Cummings, J.L., Fairbanks, L.A., Bravi, D., Calvani, M. & Carta, A. (1996) Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. American Journal of Psychiatry 153, 1438-1443.
164. Levy-Lahad, E., Wijsman, E.M., Nemens, E. et al. (1995a) Candidate gene for chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977.
165. Levy-Lahad, E., Wasko, W., Poorkaj, D.M. et al. (1995b) A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973.
166. Lewy-Lahad, E. & Bird, T.D. (1996) Genetic factors in Alzheimer's disease: a review of recent advances. Annals of Neurology 40, 829-840.
167. Li, G., Shen, Y.C., Chen, C.H. et al. (1989) An epidemiological survey of age-related dementia in an urban area of Beijing. Acta Psychiatrica Scandinavica 79, 557-563.
168. Lim, A., Tsuang, D., Kukull, W. et al. (1999) Cliniconeuropathological correlation of Alzheimer's disease in a community-based case series. Journal of the American Geriatric Society 47, 564-569.
169. Litvan, I. & FitzGibbon, E.J. (1996) Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects? Neurology 47, 1324-1326.
170. Lopez, O.L., Becker, J.T., Somsak, D., Dew, M.A. & DeKosky, S.T. (1994) Awareness of cognitive deficits and anosognosia in probable Alzheimer's disease. European Neurology 34, 277-282.
171. Lopez, O.L., Wisnieski, S.R., Becker, J.T., Boller, F. & DeKosky, S.T. (1997) Extrapyramidal signs in patients with probable Alzheimer disease. Archives of Neurology 54, 969-975.
172. Lowe, J. & Spillantini, M.G. (1998) Non-Alzheimer degenerative dementias. Brain Pathology 8, 295-297.
173. Lynch, T., Sano, M., Marder, K.S. et al. (1994) Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinson-amyotrophy complex. Neurology 44, 1878-1884.
174. Mann, D.M. (1997) A commentary of the diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Neurobiological Aging 18, S51-S52.
175. Mann, D.M., Iwatsubo, T., Cairns, N.J. et al. (1996) Amyloid ß protein (Aß) deposition in chromosome 14- linked Alzheimer's disease. Predominance of AE42(43). Annals of Neurology 40, 149-156.
176. Markesbery, W.R. (1997) Neuropathological criteria for the diagnosis of Alzheimer's disease. Neurobiological Aging 18, S13-S19.
177. Marson, D.C., Cody, H.A., Ingram, K.K. & Harrell, L.E. (1995) Neuropsychologic predictors of competency in Alzheimer's disease using a rational reasons legal standard. Archives of Neurology 52, 955-959.
178. Martin, A. (1987) Representation of semantic and spatial knowledge in Alzheimer's patients: implications for models of preserved learning in amnesia. Journal of Clinical and Experimental Neuropsychology 9, 191-224.
179. Martin, D.C., Miller, J.K., Kapoor, W., Arena, V.C. & Boller, F. (1987) A controlled study of survival with dementia. Archives of Neurology 44, 1122-1126.
180. Martyn, C.N., Barker, D.J.P., Osmond, C. et al. (1989) Geographical relation between Alzheimer's disease and aluminium in drinking water. Lancet 1, 59-62.
181. Masterman, D.L., Mendez, M.F., Fairbanks, L.A. & Cummings, J.L. (1997) Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias. Journal of Geriatric Psychiatry Neurology 10, 15-21.
182. Mattiace, L.A., Davies, P. & Dickson, D.W. (1990) Detection of HLA DR on microglia in the human brain is a function of both clinical and technical factors. American Journal of Pathology 136 (5), 1101-1114.
183. Mattson, M.P. & Guo, Q. (1999) The presenilins. Neuroscientist 5, 112-124.
184. McGeer, P.L., Itagaki, S., Tago, H. & McGeer, E.G. (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility Glycoprotein HLA-DR. Neuroscience Letters 79, 95-200.
185. McGeer, P.L., McGeer, E., Rogers, J. & Sibley, J. (1990) Anti-inflammatory drugs and Alzheimer's disease. Lancet 335, 1037.
186. McKee, A.C., Kowall, N.W., Schumacher, J.S. & Beal, M.F. (1998) The neurotoxicity of amyloid beta protein in aged primates. Amyloid 5, 1-9.
187. McKeith, I.G., Galasko, D., Kosaka, K. et al. (1996) Consensus guidelines for clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Neurology 47, 1113-1124.
188. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. & Stadlan, E.M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
189. Mega, M.S., Cummings, J.L., Fiorello, T. & Gornbein, J. (1996) The spectrum of behavioral changes in Alzheimer's disease. Neurology 46, 130-135.
190. Mendez, M.F., Catanzaro, P., Doss, R.C., Arguello, R. & Frey, W.H. 2nd. (1994) Seizures in Alzheimer's disease: clinicopathologic study. Journal of Geriatric Psychiatry and Neurology 7, 230-233.
191. Mendez, M.F., Mendez, M.A., Martin, R., Smyth, K.A. & Whitehouse, P.J. (1990) Complex visual disturbances in Alzheimer's disease. Neurology 40, 439-443.
192. Meyer, J.S., McClintic, K.L., Rogers, R.L., et al. (1988) Aetiological considerations and risk factors for multiinfarct dementia. Journal of Neurological & Neurosurgical Psychiatry 51, 1489-1497.
193. Miller, B.L., Ikonte, C., Ponton, M. et al. (1997) A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 48, 937-942.
194. Mirra, S.S. (1997) The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiological Aging 18, S91-S94.
195. Mirra, S.S., Heyman, A., McKeel, D. et al. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
196. Morris, J.C., Edland, S., Clark, C. et al. (1993) The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 43, 2457-2465.
197. Morris, J.C., Heyman, A., Mohs, R.C. et al. (1989) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39, 1159-1165.
198. Mortimer, J.A., French, L.R., Schuman, L.M. & Hutton, J.T. (1985) Head injuries in Alzheimer's disease and vascular dementia. Neurology 35, 1804.
199. Muckle, T.J. & Roy, J.R. (1985) High-density lipoprotein cholesterol in differential diagnosis of senile dementia. Lancet i, 1191-1192.
200. Neary, D., Snowden, J.S., Northen, B. & Goulding, P. (1988) Dementia of frontal lobe type. Journal of Neurological and Neurosurgical Psychiatry 51, 353-361.
201. Nilsson, L.V. & Persson, G. (1984) Prevalence of mental disorders in an urban sample examined at 70, 75 and 79 years of age. Acta Psychiatrica Scandinavica 69, 519-527.
202. Ohgami, T., Kitamoto, T., Shin, R.W., Kaneko, Y., Ogomori, K. & Tateishi, J. (1991) Increased senile plaques without microglia in Alzheimer's disease. Acta Neuropathological (Berlin) 81, 242-247.
203. Okuizumi, K., Onodera, O., Namba, Y. et al. (1995) Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature (Genetics) 11, 2207-2209.
204. Olichney, J.M., Galasko, D., Salmon, D.P. et al. (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 51, 351-357.
205. Oppenheim, G. (1994) The earliest signs of Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology 7, 116-120.
206. Ortof, E. & Crystal, H.A. (1989) Rate of progression of Alzheimer's disease. Journal of the American Geriatric Society 37, 511-514.
207. Osuntokun, B.O., Sahota, A., Ogunniyi, A. et al. (1995) Lack of an association between apolipoprotein E e4 and Alzheimer's disease in elderly Nigerians. Annals of Neurology 38, 463-465.
208. Overmyer, M., Helisalmi, S., Soininen, H., Laakso, M., Riekkinen, P.S.R. & Alafuzoff, I. (1999a) Astrogliosis and the ApoE genotype. Dementia and Geriatric Cognitive Disorders 10, 252-257.
209. Overmyer, M., Helisalmi, S., Soininen, H., Laakso, M., Riekkinen, P.S.R. & Alafuzoff, I. (1999b) Reactive microglia in aging and dementia. An immunohistochemical study of postmortem human brain tissue. Acta Neuropathologica 97, 383-392.
210. Pasquier, F., Leyes, D. & Scheltens, P. (1998) The infleunce of coincidental vascular pathology on symptomatology and course of Alzheimer's disease. Journal of Neural Transmission 54 (Suppl.), 117-127.
211. Patterson, M.B., Mack, J.L., Mackell, J.A. et al. (1997) A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study. Alzheimer's Disease and Associated Disorders 11 (Suppl. 2), S40-S44.
212. Payami, H., Kaye, J., Becker, W., Norman, D. & Wetzteon, P. (1991) HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic Alzheimer's disease in men. Neurology 41, 1544-1548.
213. Peavy, G.M., Salmon, D.P., Rice, V.A. et al. (1996) Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profile. Archives of Neurology 53, 367-372.
214. Pericak-Vance, M.A., Mass, M.P., Yamaoka, L.H. et al. (1997) Complete genomic screen in late-onset familial Alzheimer's diseaseaevidence for a new locus on chromosome 12. Journal of the American Medicine Association 278, 1237-1241.
215. Perl, D.P. & Purohit, D.P. (1997) Proposal to revise the morphologic criteria for the diagnosis of Alzheimer's disease. Neurobiological Aging 18, S81-S84.
216. Petersen, R.C., Smith, G.E., Ivnik, R.J. et al. (1995) Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. Journal of the American Medical Association 273, 1274-1278.
217. Petersen, R.C., Smith, G.E., Ivnik, R.J., Kokmen, E. & Tangalos, E.G. (1994) Memory function in very early Alzheimer's disease. Neurology 44, 867-872.
218. Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Tangalos, E.G. & Kokmen, E. (1999) Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 56, 303-308.
219. Pinessi, L., Rainero, I., Angelini, G. et al. (1983) I fattori di rischio nelle sindromi demenziali primarie. Minerva Psichiatrics 24, 87-91.
220. Poulshock, S.W. & Deimling, G.T. (1984) Families caring for elders in residence. Issues in the measurement of burden. Journal of Gerontology 39, 230-239.
221. Powers, J.M. (1997) Diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Neurobiological Aging 18, S53-S54.
222. Powers, W.J., Perlmutter, J.S., Videen, T.O. et al. (1992) Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease. Neurology 42, 765-770.
223. Preston, G. (1986) Dementia in elderly adults. Prevalence and institutionalization. Journal of Gerontology 41, 261-267.
224. Price, J.L. (1997) Diagnostic criteria for Alzheimer's disease. Neurobiological Aging 18, S67-S70.
225. Raina, A.K., Takeda, A., Nunomura, A., Perry, G. & Smith, M.A. (1999) Genetic evidence for oxidative stress in Alzheimer's disease. Neuroreport 10, 1355-1357.
226. Rapcsak, S.Z., Croswell, S.C. & Rubens, A.B. (1989) Apraxia in Alzheimer's disease. Neurology 39, 664-668.
227. Raskind, M.A., Carta, A. & Bravi, D. (1995) Is early-onset Alzheimer disease a distinct subgroup within the Alzheimer disease population? Alzheimer's Disease and Associated Disorders 9 (Suppl. 1), S2-S6.
228. Reichman, W.E., Coyne, A.C., Amirneni, S., Molino, B. Jr & Egan, S. (1996) Negative symptoms in Alzheimer's disease. American Journal of Psychiatry 153, 424-426.
229. Reiman, E.M., Uecker, A., Caselli, R.J. et al. (1998) Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Annals of Neurology 44, 288-291.
230. Reisberg, B., Borenstein, J., Salob, S.P., Ferris, S.H., Franssen, E. & Georgotas, A. (1987) Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. Journal of Clinical Psychiatry 48 (Suppl. 9), 15.
231. Reisberg, B., de Ferris, S.H., Leon, M.J. & Crook, T. (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry 139, 1136-1139.
232. Renkawek, K., Voorter, C.E.M., Bosman, G.J.C.G.M., van Workum, F.P.A. & de Jong, W.W. (1994) Expression of aB-crystalline in Alzheimer's disease. Acta Neuropathologica 87, 155-160.
233. Reynolds, C.F., Kupfer, D.J., Taska, L.S. et al. (1985) Sleep apnea in Alzheimer's dementia: correlation with mental deterioration. Journal of Clinical Psychiatry 46, 257-261.
234. Ritchie, K. & Kildea, D. (1995) Is senile dementia agerelated or ageing-related? Evidence from a meta-analysis of dementia prevalence in the oldest old. Lancet 346, 931-934.
235. Ritchie, K. & Touchon, J. (1992) Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical sub-types? Journal of Clinical Epidemiology 45, 1391-1398.
236. Ritchie, K., Kildea, D. & Robine, J.-M. (1992) The relationship between age and the prevalence of senile dementia. a meta-analysis of recent data. International Journal of Epidemiology 21, 763-769.
237. Ritchie, K., Mathers, C. & Jorm, A.F. (1994a) Dementiafree life expectancy in Australia. Australian Journal of Public Health 18, 149-152.
238. Ritchie, K., Robine, J.M., Letenneur, L. & Dartigues, J.F. (1994b) Dementia-free life expectancy in France. American Journal of Public Health 84, 232-236.
239. Roelands, M., Van Oyen, H. & Baro, F. (1994) Dementiafree life expectancy in Belgium. European Journal of Public Health 4 (1), 33-37.
240. Rogaev, E.I., Sherrington, R., Rogaeva, E.A. et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to Alzheimer's disease type 3 gene. Nature 376, 775-778.
241. Rogers, J., Luber-Narod, J., Styren, S.D. & Civin, W.H. (1988) Expression of immune system-associated antigens by cells of the human central nervous system relationship to the pathology of Alzheimer's disease. Neurobiological Aging 9, 339-349.
242. Romanelli, M.F., Morris, J.C., Ashkin, K. & Coben, L.A. (1990) Advanced Alzheimer's disease is a risk factor for late-onset seizures. Archives of Neurology 47, 847-850.
243. Rubin, E.H., Morris, J.C., Grant, E.A. & Vendegna, T. (1989) Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Archives of Neurology 46, 379-382.
244. Salmon, D.P., Thal, L.J., Butters, N. & Heindel, W.C. (1990) Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology 40, 1225-1230.
245. Sandbrink, R., Hartmann, T., Masters, C.L. & Beyreuther, K. (1996) Genes contributing to Alzheimer's disease. Molecular Psychiatry 1, 27-40.
246. Sasaki, A. & Nakazato, Y. (1992) The identity of cells expressing MHC class II antigen in normal and pathologic human brain. Neuropathological Applied Neurobiology 18, 13-26.
247. Schellenberg, G.D., Bird, T.D., Wijsman, E.M. et al. (1992) Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258, 668-671.
248. Scheltens, P., Launer, L.J., Barkhof, F., Weinstein, H.C. & Jonker, C. (1997) The diagnostic value of magnetic resonance imaging and technetium 99m- HMPAO singlephoton- emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population. Alzheimer's Disease and Associated Disorders 11, 63-70.
249. Scheuner, D., Eckman, C., Jensen, M. et al. (1996) The amyloid β protein deposited in the senile plaques of Alzheimer's disease is increased in vivo by presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature (Medicine) 2, 864-870.
250. Schmechel, D.E., Saunders, A.M., Strittmatter, W.J. et al. (1993) Increased amyloid-β peptide deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proceedings of the National Academy of Sciences 90, 9649-9653.
251. Schneider, L.S. (1992) Tracking dementia by the IMC and the MMSE. Journal of the American Geriatric Society 40, 537-538.
252. Schoenberg, B.S., Okazaki, H. & Kokmen, E. (1985) Reduced survival in patients with dementia: a population study. Archives of Neurology 42, 740-743.
253. Scinto, L.F., Daffner, K.R., Dressler, D. et al. (1994) A potential noninvasive neurobiological test for Alzheimer's disease. Science 266, 1051-1054.
254. Scott, W.K., Edwards, K.B., Davis, D.R., Cornman, C.B. & Macera, C.A. (1997) Risk of institutionalization among community long-term care clients with dementia. Gerontologist 37, 46-51.
255. Seltzer, B., Vasterling, J.J., Yoder, J.A. & Thompson, K.A. (1997) Awareness of deficit in Alzheimer's disease: relation to caregiver burden. Gerontologist 37, 20-24.
256. Severson, M.A., Smith, G.E., Tangalos, E.G. et al. (1994) Patterns and predictors of institutionalization in community-based dementia patients. Journal of the American Geriatrics Society 42, 181-185.
257. Sherrington, R., Rogaev, E.I., Laing, Y. et al. (1995) Cloning of a gene bearing missense mutations in earlyonset familial Alzheimer's disease. Nature 375, 754-760.
258. Shoffner, J.M., Brown, M.D., Torroni, A. et al. (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson's disease patients. Genomic 17, 171-184.
259. Shuttleworth, E.C. & Huber, S.J. (1988) The naming disorder of dementia of Alzheimer type. Brain and Language 34, 222-234.
260. Smale, G., Nichols, N.R., Brady, D.R., Finch, C.E. & Horton, W.E. Jr. (1995) Evidence for apoptotic cell death in Alzheimer's disease. Experimental Neurology 133, 225-230.
261. Soininen, H. & Heinonen Op. (1982) Clinical and etiological aspects of senile dementia. European Neurology 21, 401-410.
262. Soininen, H., Kosunen, O., Helisalmi, S. et al. (1995) A severe loss of choline acetyltransferase in the frontal cortex of patients carrying apolipoprotein E e4 allele. Neuroscience Letters 187, 79-82.
263. St George-Hyslop, P.H., Tanzi, R.E., Polinsky, R.J. et al. (1987) The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235, 885-890.
264. Starkstein, S.E., Sabe, L., Chemerinski, E., Jason, L. & Leiguarda, R. (1996) Two domains of anosognosia in Alzheimer's disease. Journal of Neurological and Neurosurgical Psychiatry 61, 485-490.
265. Stern, R.G., Mohs, R.C., Davidson, M. et al. (1994) A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. American Journal of Psychiatry 151, 390-396.
266. Stern, Y., Albert, M., Brandt, J. et al. (1994) Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors' Study. Neurology 44, 2300-2307.
267. Stern, Y., Tang, M.X., Albert, M.S. et al. (1997) Predicting time to nursing home care and death in individuals with Alzheimer disease. Journal of the American Medical Association 277, 806-812.
268. Storandt, M., Botwinick, J., Danziger, W.L., Berg, L. & Hughes, C.P. (1984) Psychometric differentiation of mild senile dementia of the Alzheimer type. Archives of Neurology 41, 497-499.
269. Strittmatter, W.J., Saunders, A.M., Schmechel, D. et al. (1993) Apolipoprotein E: high-avidity binding to ß-amyloid increased frequency of type 4 allele in lateonset familial Alzheimer's disease. PNAS 90, 1977-1981.
270. Styren, S.D., Civin, W.H. & Rogers, J. (1990) Molecular, cellular and pathologic characterization of HLA DR immunoreactivity in normal elderly and Alzheimer's disease brain. Experimental Neurology 110, 93-104.
271. Sulger, J., Dumais-Huber, C., Zerfass, R., Henn, F.A. & Aldenhoff, J.B. (1999) The calcium response of human T lymphocytes is decreased in aging but increased in Alzheimer's dementia. Biological Psychiatrics 45, 737-742.
272. Talbot, P.R., Lloyd, J.J., Snowden, J.S., Neary, D. & Testa, H.J. (1998) A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? Journal of Neurological and Neurosurgical Psychiatry 64, 306-313.
273. Tamaoka, A., Odaka, A., Ishibashi, Y. et al. (1994) APP. 717 mis-sense mutation affect the ration of amyloid (species (A (1-42/43 and A (1-40) in familial Alzheimer brain. Journal of Biological Chemistry 269, 32721-32724.
274. Tang, M.X., Jacobs, D., Stern, Y. et al. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432.
275. Teri, L., Larson, E.B. & Reifler, B.V. (1988) Behavioral disturbance in dementia of the Alzheimer's type. Journal of the American Geriatric Society 36, 1-6.
276. Thal, L.J., Grundman, M. & Klauber, M.R. (1988) Dementia: characteristics of a referral population and factors associated with progression. Neurology 38, 1083-1090.
277. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiology of Aging 18, S1-S2.
278. Tierney, M.C., Szalai, J.P., Snow, W.G. et al. (1996) Prediction of probable Alzheimer's disease in memoryimpaired patients: a prospective longitudinal study. Neurology 46, 661-665.
279. Tomlinson, B.E., Blessed, G. & Roth, M. (1970) Observations on the brains of demented old people. Journal of Neurological Science 11, 205-242.
280. Tooyama, I., Kimura, H., Akiyama, H. & McGeer, P.L. (1990) Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease. Brain Research 523, 273-280.
281. Treves, T. & Korczyn, A.D. & Zilber, N. (1986) Presenile dementia in Israel. Archives of Neurology 43, 26-29.
282. Trojanowski, J.Q., Clark, C.M., Schmidt, M.L., Arnold, S.E. & Lee, V.M. (1997) Strategies for improving the postmortem neuropathological diagnosis of Alzheimer's disease. Neurobiological Aging 18, S75-S79.
283. van Belle, G., Uhlmann, R.F., Hughes, J.P. & Larson, E.B. (1990) Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer type. Journal of Clinical Epidemiology 43, 589-595.
284. Victoroff, J., Mack, W.J., Lyness, S.A. & Chui, H.C. (1995) Multicenter clinicopathological correlation in dementia. American Journal of Psychiatry 152, 1476-1484.
285. Victoroff, J., Ross, G.W., Benson, D.F., Verity, M.A. & Vinters, H.V. (1994) Posterior cortical atrophy. Neuropathologic correlations. Archives of Neurology 51, 269-274.
286. Vitaliano, P.P., Russo, J., Breen, A.R., Vitiello, M.V. & Prinz, P.N. (1986) Functional decline in the early stages of Alzheimer's disease. Psychological Aging 1, 41-46.
287. Volicer, L., Hurley, A.C., Lathi, D.C. & Kowall, N.W. (1994) Measurement of severity in advanced Alzheimer's disease. Journal of Gerontology 49, M223-M226.
288. Wade, J.P.H., Mirsen, T.R., Hachinski, V.C., Fisman, M., Lau, C. & Merskey, H. (1987) The clinical diagnosis of Alzheimer's disease. Archives of Neurology 44, 24-29.
289. Walsh, J.S., Welch, H.G. & Larson, E.B. (1990) Survival of outpatients with Alzheimer-type dementia. Annals of Internal Medicine 113, 429-434.
290. Wavrant-DeVrieze, F., Lambert, J.C., Stas, L. et al. (1999) Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease. Human Genetics 5, 432-434.
291. Weideman, A., Paliga, K., Durrwang, U. et al. (1997) Formation of stable complexes between two Alzheimer's disease gene products, preselinin 2 and b-amyloid precursor protein. Nature (Medicine) 3, 328-332.
292. Welch, H.G., Walsh, J.S. & Larson, E.B. (1992) The cost of institutional care in Alzheimer's disease: nursing home and hospital use in a prospective cohort. Journal of the American Geriatric Society 40, 221-224.
293. Welsh, K., Butters, N., Hughes, J., Mohs, R. & Heyman, A. (1991) Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Archives of Neurology 48, 278-281.
294. West, M.J., Coleman, P.D., Flood, D.J. & Troncoso, J.S. (1994) Difference in the pattern of hippocampal neuronal loss in normal aging and Alzheimer's disease. Lancet 344, 769-772.
295. Wilcock, G.K. & Esiri, M.M. (1982) Plaques, tangles and dementia. Journal of Neurological Science 56, 343-356.
296. Wilkie, F. & Eisdorfer, C. (1971) Intelligence and blood pressure in the aged. Science 172, 959-962.
297. Wisniewski, H.M. & Silverman, W. (1997) Diagnostic criteria for the neuropathological assessment of Alzheimer's disease: current status and major issues. Neurobiological Aging 18, S43-S50.
298. Wisniewski, H.M., Bancher, C., Barcikowska, M., Wen, G.Y. & Currie, J. (1989) Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathologica 78, 337-347.
299. Wisniewski, H.M., Narang, H.K. & Terry, R.D. (1976) Neurofibrillary tangles of paired helical filaments. Journal of Neurological Science 17, 173-181.
300. Wisniewski, H.M., Narang, H.K., Corsellis, J.A.N. & Terry, R.D. (1976) Ultrastructural studies of the neuropil and neurofibrillary tangles in Alzheimer's disease and post-traumatic dementia. Journal of Neuropathology and Experimental Neurology 35, 367.
301. Wisniewski, T., Ghiso, J. & Frangione, B. (1994) Alzheimer's disease and soluble Aß. Neurobiological Aging 15, 143-152.
302. World Health Organization (1970) International Classification of Diseases, 9th edn. World Health Organization, Geneva.
303. World Health Organization. (1992) Mental and behavioral disorders (F00-F99). In: The International Classification of Diseases, ICD-10, 10th revision, pp. 311-388. World Health Organization, Geneva.
304. Yanker, B.A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
305. Zhang, M.Y., Katzman, R., Salmon, D. et al. (1990) The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender and education. Annals of Neurology 4, 428-437.
306. Zhou, J., Liyangage, U., Medina, M. et al. (1997) Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport 8, 1489-1494.